US$ 24.88
glp 1 tirzepatide compound Bk-Tirzepatide Injectable Tirzepatide | Compounded GLP-1/GIP
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Discover effective Weightmanagement with Weightless Patches, infused with natural ingredients like berberine and pomegranate to boost metabolism and curb cravings naturally.

Trusted by 200+ providers.

They won't get the real medication in "GLP-1 patches," doctors warn.
PlexusDx offers compounded semaglutide and tirzepatide options starting as low as $129 per month, with no insurance requirement or membership fees

They are commonly used within provider-guided wellness protocols designed to support balanced eating habits, routine consistency, and overall metabolic function
